Target intelligence / Profile preview

YAE1 divergent transcript

Molecular classification
Other (divergent noncoding transcript; antisense noncoding RNA)
01

Overview

YAE1 divergent transcript refers to RNA molecules transcribed from the promoter region of the YAE1 gene in the *divergent* (antisense or opposite) direction, characteristic of promoter bidirectionality seen in eukaryotic genomes. These molecules are typically *unstable, rapidly degraded*, and largely noncoding. While the phenomenon of divergent transcription is widespread and may play a role in *local regulation of gene expression or chromatin structure*, individual divergent transcripts—including YAE1-DT—are *not considered standalone molecular targets*. The presence and regulation of divergent transcripts can be influenced by sequence-specific transcription factors (like Rap1 in yeast), chromatin remodelers, and local promoter architecture[2][3][4]. If you are seeking structured information for database use or drug discovery, YAE1-DT does not correspond to a canonical target—such as an enzyme, receptor, ion channel, or transcription factor—with established roles in pathophysiology, pharmacology, or therapeutics[2][4].

Other names
YAE1-DTYAE1 divergent noncoding RNA
02

Mechanism of action

None (No characterized mechanism of action; pharmacological targeting does not apply.)

03

Biological functions

Other (No confirmed or characterized biological function; these transcripts may participate in regulation of local chromatin structure or transcription, or may simply represent transcriptional noise)
04

Disease associations

Other (No confirmed disease association or role in pathology; divergent noncoding transcripts are generally not characterized as disease-related)

Beyond the preview

Go deeper on YAE1 divergent transcript.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on YAE1 divergent transcript.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call